Searched for
CYTOSORBENTS CORPORATION
Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 27%After being relentless sellers for a large part of the calendar year 2025, FPI numbers for October have turned positive. This is the second...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have a big element of probability. The way things have panned out in the past few weeks, it is very likely that the bulls will ...
- Ignore noise on the street, stick to basics: 5 stocks from different sectors with an upside potential of up to 38%The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%In the last few weeks, the range in which the nifty had been moving has become broader as the volatility has increased both due to internat...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside scope of over 20%As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....
- These largecaps have ‘strong buy’ & ‘buy’ recos with upside potential of over 20%In volatile markets, where there is a readjustment in valuation across midcap space, it is only a matter of time that the concept of relati...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%While the correction has been going on in the market since the middle of July, it is only on days like Monday where everyone on the street ...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...
- These largecaps have ‘strong buy’ & ‘buy’ reco and upside potential of over 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of over 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of financial instit...
- These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of financial instit...
- Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%In an already volatile market, bears are being helped by global events. However there are few large cap stocks which are finding favor with...
- Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%In otherwise volatile markets, bulls are once again making an attempt to come back. There are few large cap stocks which are finding favor ...
- Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%As the market witnesses volatile movement and bearish bias once again comes back to the street. There are few large cap stocks which are st...
- Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%As the market witnesses volatile movement and bearish bias once again comes back to the street. There are few large cap stocks which are st...
- A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...
- Biocon, CytoSorbents expand pact to treat body inflammationCompanies have expanded the scope of their strategic partnership for cytokine reduction therapy, CytoSorb, to treat patients experiencing s...
- Biocon inks pact with US firm for sepsis treatment therapyKiran Mazumdar Shaw said the partnership will enable the company to address the huge unmet need of sepsis management in India and emerging ...
Load More
